| Study samples | Prevalence in population$ |  | |||
---|---|---|---|---|---|---|
 | Control area | SMC area | Control area (%) | SMC area (%) | Prevalence ratio^ | p-value |
 |  |  |  |  | SMC/ non SMC (95% CI) |  |
Prevalence of parasitaemia among children surveyed | 41/3320 | 9/3326 | 1.33 | 0.22 | 0.16 (0.06, 0.42) | <0.001 |
Prevalence of mutations among typed | Â | Â | Â | Â | Â | |
dhfr triple (51, 59, 108) | 27/34 | 4/6 | 0.98 | 0.18 | 0.18 (0.059, 0.58) | 0.004 |
dhps-437 | 25/35 | 4/6 | 0.88 | 0.18 | 0.21 (0.064, 0.66) | 0.008 |
SP resistant mutant (dhfr triple + dhps 437) | 23/34 | 4/6 | 0.84 | 0.18 | 0.22 (0.068, 0.69) | 0.01 |
crt CVIET mutation | 13/35 | 3/6 | 0.46 | 0.14 | 0.30 (0.10, 0.86) | 0.026 |
mdr 86Y | 15/33 | 4/6 | 0.56 | 0.18 | 0.32 (0.11, 0.92) | 0.034 |
mdr 184F | 28/34 | 5/6 | 1.02 | 0.23 | 0.22 (0.086, 0.58) | 0.002 |
AQ resistant mutant (mdr 86Y + crt CVIET) | 9/33 | 2/6 | 0.34 | 0.09 | 0.27 (0.078, 0.92) | 0.036 |
SP resistant & AQ resistant | 8/32 | 2/6 | 0.31 | 0.09 | 0.29 (0.08, 1.07) | 0.064 |